PLUS THERAPEUTICS Files 8-K on Security Holder Vote Matters
Ticker: PSTV · Form: 8-K · Filed: Aug 12, 2025 · CIK: 1095981
| Field | Detail |
|---|---|
| Company | Plus Therapeutics, Inc. (PSTV) |
| Form Type | 8-K |
| Filed Date | Aug 12, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $50,000,000, $1,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, shareholder-vote
TL;DR
PLUS THERAPEUTICS is holding a shareholder vote on key matters.
AI Summary
On August 7, 2025, PLUS THERAPEUTICS, INC. filed an 8-K report detailing a submission of matters to a vote of security holders. The company, formerly known as CYTORI THERAPEUTICS, INC. and MACROPORE INC, is incorporated in Delaware and headquartered in Austin, Texas.
Why It Matters
This filing indicates that important decisions requiring shareholder approval are being put forth, which could impact the company's strategic direction and future operations.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- PLUS THERAPEUTICS, INC. (company) — Registrant
- CYTORI THERAPEUTICS, INC. (company) — Former company name
- MACROPORE INC (company) — Former company name
- August 7, 2025 (date) — Date of earliest event reported
- August 12, 2025 (date) — Filing date
FAQ
What specific matters are being submitted for a vote of security holders?
The filing does not specify the exact matters being submitted for a vote, only that such a submission is occurring.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on August 7, 2025.
What is the principal executive office address for PLUS THERAPEUTICS, INC.?
The address is 2710 Reed Road, Suite 160, Houston, Texas 77051.
What is the company's telephone number?
The company's telephone number is (737) 255-7194.
What were the previous names of PLUS THERAPEUTICS, INC.?
The company was formerly known as CYTORI THERAPEUTICS, INC. and MACROPORE INC.
Filing Stats: 937 words · 4 min read · ~3 pages · Grade level 10.5 · Accepted 2025-08-12 16:31:04
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 PSTV The Nasdaq Capital Market Ind
- $50,000,000 — ale of (i) up to Fifty Million Dollars ($50,000,000) of shares of our common stock and (ii)
- $1,000,000 — ock and (ii) up to One Million Dollars ($1,000,000) of shares of our common stock as a com
Filing Documents
- d71976d8k.htm (8-K) — 39KB
- 0001193125-25-179012.txt ( ) — 151KB
- pstv-20250807.xsd (EX-101.SCH) — 2KB
- pstv-20250807_lab.xml (EX-101.LAB) — 18KB
- pstv-20250807_pre.xml (EX-101.PRE) — 11KB
- d71976d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 12, 2025 PLUS THERAPEUTICS, INC. By: /s/ Marc H. Hedrick, M.D. Marc H. Hedrick, M.D. President and Chief Executive Officer